Latest News About Meningococcal Disease

Here’s a concise update on the latest meningococcal disease news.

• The CDC and multiple outlets have highlighted a surge in invasive meningococcal disease in the United States, driven largely by a particular strain (commonly linked to serogroup Y) and affecting adults in the 30–60 age range. This has prompted updated alerts to healthcare providers and reinforced vaccination recommendations.[2][4][7]
• In 2024, provisional CDC surveillance data indicated the largest annual number of US meningococcal disease cases since 2013, with hundreds of confirmed/probable cases reported and notable regional patterns; vaccination remains a key preventive strategy.[3][4][5]
• Public health agencies stress early recognition of symptoms (fever, headache, neck stiffness, atypical joint or body pains, rash) and prompt medical care, as invasive disease can progress rapidly despite treatment. Vaccination against meningococcal disease (including vaccines covering multiple serogroups) is emphasized for at-risk populations.[1][4][2]

If you’d like, I can pull a brief regional snapshot (e.g., Malta or Europe) and summarize current guidance, vaccination recommendations, and recent case counts, with sources.